Synta completes follow-on

Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Lexington, Mass. Business: Cancer, Autoimmune Date completed: 1/6/12 Type: Follow-on Raised: $30.8 million Shares: 7 million Price: $4.40 Shares after offeri...